ARTICLE | Company News
Europroteome, Genmab deal
May 23, 2005 7:00 AM UTC
GEN acquired rights to 16 cancer targets to treat non-steroid dependent cancers of epithelial cell origin, such as gastrointestinal cancers, from the insolvency administrator of Europroteome (Hennigsd...